Avidity Biosciences (RNA)
(Delayed Data from NSDQ)
$43.52 USD
+0.67 (1.55%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $43.47 -0.05 (-0.11%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.80 |
EPS Last Quarter | -0.65 |
Last EPS Surprise | 14.47% |
ABR | 1.11 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.96 |
Next Year | -3.10 |
EPS (TTM) | -2.94 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 7.09M | 7.09M | 13.66M | 24.19M |
# of Estimates | 1 | 1 | 3 | 2 |
High Estimate | 7.09M | 7.09M | 19.77M | 28.37M |
Low Estimate | 7.09M | 7.09M | 5.60M | 20.00M |
Year ago Sales | 2.82M | 2.19M | 9.56M | 13.66M |
Year over Year Growth Est. | 151.42% | 223.74% | 42.85% | 77.10% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.80 | -0.70 | -2.96 | -3.10 |
# of Estimates | 4 | 2 | 6 | 5 |
Most Recent Consensus | -0.70 | -0.70 | -2.53 | -2.80 |
High Estimate | -0.56 | -0.53 | -2.50 | -2.24 |
Low Estimate | -0.94 | -0.87 | -3.51 | -3.90 |
Year ago EPS | -0.71 | -0.79 | -2.91 | -2.96 |
Year over Year Growth Est. | -12.68% | 11.39% | -1.72% | -4.98% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 2 | 4 | 4 |
Up Last 60 Days | 2 | 2 | 4 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 2 | 1 |
Down Last 60 Days | 0 | 0 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.80 | -0.70 | -2.96 | -3.10 |
7 Days Ago | -0.80 | -0.70 | -2.96 | -3.10 |
30 Days Ago | -0.76 | -0.76 | -3.15 | -3.28 |
60 Days Ago | -0.76 | -0.76 | -3.15 | -3.28 |
90 Days Ago | -0.76 | -0.76 | -3.10 | -3.28 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.80 | -0.70 | -2.96 | -3.10 |
Zacks Consensus Estimate | -0.80 | -0.70 | -2.96 | -3.10 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.65 | -0.79 | -0.79 | -0.71 | NA |
Estimate | -0.76 | -0.81 | -0.54 | -0.76 | NA |
Difference | 0.11 | 0.02 | -0.25 | 0.05 | -0.02 |
Surprise | 14.47% | 2.47% | -46.30% | 6.58% | -5.70% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more